MapLight Therapeutics CMO Erin Foff sells $124,068 in stock
Reported by Investing.com · investing.com ·
Story context
What to watch: This report cites a concrete figure ($124,068) — compare it against the trailing trend before treating one data point as a turning point.
Latest session change: $MPLT -3.99%
How this was labelled
Investing.com published this one, and Wook filed it under Healthcare & Pharma. The automated reading is neutral, at low severity. It was matched to $MPLT. The headline or preview carried 1 figure — $124,068 — shown above exactly as published. Nothing was recalculated. The publisher gave no preview text for this story, so only the headline appears above. Nothing has been written in to fill the gap.
When it landed
This one landed after the closing bell, so the session change shown beside it had already finished before the story existed. The first session that could react to it is the next one.
Where the price is
$MPLT last traded at $7.70, -3.99% on the session. That is within a tenth of its 52-week low; the year runs $7.46 to $40.43. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 4 stories about these names in the last 30 days, 2 of them this week. Most of that arrived in the last week, so the coverage is concentrated rather than steady. Across the whole run the wording has leaned bearish: 0% bullish, 75% neutral, 25% bearish. 3 of them came from Investing.com itself, so some of what looks like broad coverage is one outlet returning to the story. 12 are listed beside this one if you want to follow the trail yourself.
What is already on the calendar
$MPLT earnings in 48 days. These are dates Wook already holds for the companies in this story. They are here because they are scheduled, not because this story has anything to do with them.
What this page is not saying
The tone and severity labels come from matching the headline and preview against a fixed word list — no editor and no AI — so they describe how a story is worded, not what it will do, and the tone percentages above count wording rather than anyone's view. They are not a forecast, not a member vote, and not a recommendation. Any figures are copied from the headline or preview rather than worked out here, and a price move on the same day does not mean this story caused it. None of this is investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.